291. ヒルシュスプルング病(全結腸型又は小腸型) Disease details / Clinical trials / Drug dev / DR info /


臨床試験数 : 12 / 薬物数 : 24 - (DrugBank : 15) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0

薬物ごとの開発者(Primary Sponsor)、臨床試験情報(抜粋)です。
Bifico
   Tongji Hospital
      2008   Phase 0   NCT01934959   -
Butyrate enemas + routine management
   Assistance Publique Hopitaux De Marseille
      2019   Phase 3   NCT03660176   France;
Cefazolin
   McMaster University
      2018   -   NCT03593252   -
Erythromycin
   McMaster University
      2018   -   NCT03593252   -
Gold
   Radboud University
      2021   -   NCT04624334   Netherlands;
   Xinhua Hospital, Shanghai Jiaotong University School of Medicine
      2020   Phase 0   ChiCTR2000035860   China;
High dose lactulose
   Tongji Hospital
      2013   -   NCT02216994   China;
Indocyanine green
   Lawson Health Research Institute
      2021   Phase 3   NCT04904081   Canada;
Kanamycin
   McMaster University
      2018   -   NCT03593252   -
Metronidazole
   McMaster University
      2018   -   NCT03593252   -
Oral probiotic
   Tongji Hospital
      2009   Phase 0   NCT01985646   -
Probiotics
   Cairo University
      2014   Phase 4   NCT02343562   Egypt;
   Tongji Hospital
      2014   -   NCT02350088   China;
Racol
   University of Tsukuba Hospital
      2016   -   JPRN-UMIN000024993   Japan;
SPY imaging
   St. Justine's Hospital
      2020   -   NCT04020939   Canada;
Senna
   McMaster University
      2018   -   NCT03593252   -
Sodium Picosulfate, Magnesium Oxide and Citric Acid
   McMaster University
      2018   -   NCT03593252   -
Supplement nutritional supporting
   Tongji Hospital
      2021   -   NCT04598841   China;
Surgery treatment
   Tongji Hospital
      2009   Phase 0   NCT01985646   -
VSL#3
   University of Michigan
      2006   Phase 2   NCT00630838   United States;